The drug was being tested in patients with major depressive disorder as an adjunct to be used along with other approved antidepressants. Relmada said it had begun to explore strategic alternatives, without a timeline for the completion of the process.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/twA8zfR
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment